International Consortium for Personalised Medicine


Related articles

ICPerMed Mapping Database & State of the Art Report 2017 :

19 June 2018 – The International Consortium for Personalised Medicine (ICPerMed) launched the ICPerMed mapping database on funding for research in personalised medicine, and published its first “State of the Art Report 2017”. 
read more: ICPerMed Mapping Database & State of the Art Report 2017.

Brazilian Oswaldo Cruz Foundation joined ICPerMed :

ICPerMed welcomes the Brazilian Oswaldo Cruz Foundation (Fundação Oswaldo Cruz – FIOCRUZ) as its new member. 
read more: Brazilian Oswaldo Cruz Foundation joined ICPerMed .

ICPerMed Executive Committee Meeting in Vienna :

In April 2018, the ICPerMed Executive Committee met in Vienna, Austria to discuss and plan strategy and future activities of the consortium. The meeting was hosted by the Austrian partners, BMBWF, BMASGK and MedUniWien. 
read more: ICPerMed Executive Committee Meeting in Vienna.

ICPerMed Interview in the ERA-LEARN Newsletter :

The latest newsletter of the EU-funded ERA-LEARN consortium features an interview with Ulrike Bußhoff of the ICPerMed Secretariat aswell as an analysis on the public-pubic and public-private partnership landscape related to health research. The newsletter and the analysis are both available on the ERA-LEARN website. 
read more: ICPerMed Interview in the ERA-LEARN Newsletter.

ICPerMed Conference – Registration open :

7 June 2018 – The registration of the first conference 'Personalised Medicine in Action' of the International Consortium for Personalised Medicine (ICPerMed) is now open. The conference will take place in Berlin, Germany, on November 20-21 and will focus on best practice examples for successful implementation of personalised medicine approaches. The preliminary programme is also available now.  
read more: ICPerMed Conference – Registration open.

Statement concerning the 1 Million Genomes Declaration :

On 10 April 2018 13 Member States signed a declaration, initiated by the European Commission, to establish access to 1 Million Genomes in the EU by 2022. ICPerMed has followed with interest the process of developing the declaration. Recognising the great potential of personalised medicine to improve the prevention and diagnosis of disease and the treatment of patients, ICPerMed aims to coordinate and foster research to develop and evaluate personalised medicine approaches. 
read more: Statement concerning the 1 Million Genomes Declaration.

ICPerMed Partnering Tool

The ICPerMed Partnering Tool facilitates networking among universities, research and patient organizations, SMEs, industry and all other stakeholders interested in personalised medicine. The ICPerMed Partnering Tool offers you to search for partners and to present your expertise to the personalised medicine research community. By completing and activating your profile you publish your partnering profile to all users and present your collaboration offers.
>> read more